# Benitec Biopharma Inc.: Form 8-K, filed Feb 13, 2023

- Company: [Benitec Biopharma Inc.](/companies/bntc.md) (CIK 1808898)
- Form: 8-K
- Filed: 2023-02-13
- Accepted by EDGAR: Feb 13, 2023, 08:03 ET
- Period: 2023-02-13
- Accession: 0001193125-23-034348
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1808898/000119312523034348/d375301d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1808898/000119312523034348/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1808898/000119312523034348/d375301d8k.htm

Filed Feb 13, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-034348. Last ingested by Listed: Nov 14, 2026, 11:28 ET. No prices; not investment advice.
